Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481156 · ClinicalTrials.gov registry record · Phase 3
Functional Neuroimaging Effects of Cognitive Remediation Training
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00481156: Completed Phase 3 study, sponsored by University of Minnesota.
NCT00481156 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 30 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00481156, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine behavioral and functional brain changes occuring as a result of cognitive remediation training in patients with schizophrenia. Extension and specificity of related changes will also be examined.
Primary Outcome
N-Back Performance
Interventions
- BEHAVIORAL Cognitive Remediation
- BEHAVIORAL Cognitive Behavioral Social Skills Training
- OTHER Retest in Health Controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-03-01 |
| Est. Completion | 2007-02-28 |
| Phase | Phase 3 |
What the finished NCT00481156 record still lists
NCT00481156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive Remediation is the first listed.
NCT00481156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00481156 about?
NCT00481156 is a clinical study titled "Functional Neuroimaging Effects of Cognitive Remediation Training". The purpose of this study is to examine behavioral and functional brain changes occuring as a result of cognitive remediation training in patients with schizophrenia. Extension and specificity of related changes will also be examined.
What is the current status of trial NCT00481156?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2005-03-01. Estimated completion is 2007-02-28.
What interventions are being tested in trial NCT00481156?
The interventions under investigation include: Cognitive Remediation (BEHAVIORAL), Cognitive Behavioral Social Skills Training (BEHAVIORAL), Retest in Health Controls (OTHER).
Who is sponsoring clinical trial NCT00481156?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00481156's enrollment target sits among peer trials
30 1917th of 2000 higher than 68 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI